
ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated…
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated…
A procedure that may help personalise anticancer therapies has just been developed by the CNRS,…
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy…
Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are…
Immunotherapy for cancer has made great advances and many patients can now receive effective treatments…
Cutaneous angiosarcoma is a rare, highly aggressive skin tumour found primarily on the scalps of…
Scientists are beginning to unravel one of the biggest challenges with immunotherapy: why some people…
Immunotherapy is a cancer treatment that helps the patient’s immunological system to combat it and…
Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National…
It is still a glance into the future: The combination of carbon ion and immune…